Skip to main content
Ingredients/Compound/Monolaurin (Lauric Acid Derivative)

Monolaurin (Lauric Acid Derivative).

Strength pending.The research strength is not set yet.

From coconut. Disrupts lipid envelopes of viruses and bacteria. Antimicrobial. Dissolves lipid envelopes of viruses and bacteria.

600 to 1,800mgDaily amount765Studies read

Reviewed March 2026

MLCompound
Monolaurin (Lauric Acid Derivative)IngredientMD
Category
Compound

Also filed under
AntiviralAntibacterialEnvelope disruption

What Monolaurin (Lauric Acid Derivative) is, and what it does.

Does it work
Moderate. Strong lab data. Clinical trials catching up.
How much to take
Start with 600mg a day and work up toward 1,800mg. That's the band a daily habit runs on. The 3,000mg used in research is a study condition, not a daily target.
Time to feel it
Taken daily, this runs in the background. There's no measured onset in people, so nobody can hand you a week-by-week curve yet.
The first dose
Day one is usually uneventful. Some people notice mild digestive rumbling when they start near the top of the band, which is why building up gradually suits most people.
With regular use
Variable. Acute issues faster. Chronic issues need months.
How well tolerated
Start low. Die-off reactions possible. Generally well tolerated.
How it feels
Usually nothing. Herx reactions if killing off infections.
The overlooked benefit
Chain length decides the route, not the label. The twelve-carbon fat it releases travels largely by the portal vein rather than the lymphatic path long-chain fats take.

600 to 1,800mg a day is where Monolaurin (Lauric Acid Derivative) works.

How much to take a dayLimited data
600 to 1,800mg
Daily maintenanceThe everyday amount, and where most daily supplements sit. This is the one you take month after month.
3,000mgClinical territory. Trials run high on purpose, for a set number of weeks, against one measured outcome. Impressive to hit, and not what a daily product is for.
Above 4,500mgPast what the research covers. More capsules rather than more effect.
MORE EFFECT ↑01,800mg3,000mg plateauDAILY DOSE →
The shaded band is where the dosing trials landed.

Source: Preuss et al., J Med Food, 2005; in vitro antimicrobial data

The proof, claim by claim.

These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.

Monolaurin (Lauric Acid Derivative) has emerging evidence. Based on 765+ studies.

  • Activity against lipid-enveloped organisms in cultureIn vitro study
  • Insertion into and permeabilisation of lipid bilayersIn vitro study
  • Portal transport of medium-chain fatty acids released in the gutNarrative review
  • Emulsifier function in oil and water mixturesNarrative review
  • Immune cell signalling responsesAnimal study
PubMedCochraneClinicalTrials.govNIH ODSSUPP.AI765 studies readLabs test. IngredientMD verifies.PubMedCochraneClinicalTrials.govNIH ODSSUPP.AI765 studies readLabs test. IngredientMD verifies.

Questions people ask about Monolaurin (Lauric Acid Derivative).

When should I take it?
Timing matters less than consistency. Pick a time that works for you and take it daily.
Can I take it with other supplements?
Usually fine. The main thing to watch is not doubling up on the same ingredient from different products. If you're on prescription meds, check with your pharmacist first.
Any side effects to watch for?
Most people tolerate it well at recommended doses. GI upset is the most common complaint with any supplement. Start with a lower dose and work up. If something feels off, stop and reassess.
Who benefits most from this?
People who've already covered the basics (diet, sleep, exercise) and want to fine-tune. It's not essential, but could be worthwhile for the right person.
Pairs well with19 on file

Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.

Monolaurin (Lauric Acid Derivative) + Caprylic Acidmembrane-active medium chain lipids

Monolaurin and caprylic acid are both amphipathic medium chain lipids that insert into and destabilise lipid bilayers, which is why they appear together in the same formulas. They partition into membranes of different composition.

Monolaurin (Lauric Acid Derivative) + MCT Oillipid carrier and shared source

Monolaurin is the monoglyceride of lauric acid, a C12 chain from the same coconut fraction that yields MCT oil, and it is poorly water dispersible on its own. A medium chain lipid vehicle keeps it in a lipid phase through the upper gut.

Carvacrol from oregano and monolaurin both act at the lipid membrane but by different routes, one as a small phenol that raises permeability and one as a monoglyceride that disorders the bilayer. They are combined in practice for that complementarity.

Monolaurin (Lauric Acid Derivative) + Lactoferrincomplementary non-lipid mechanism

Lactoferrin works by sequestering free iron and by binding bacterial surface structures, which is separate from the membrane-partitioning action of monolaurin. Formulas pair them so the two arms do not overlap.

Oleuropein and its hydrolysis product hydroxytyrosol act as phenolic membrane-permeabilising agents, a different chemistry from a monoglyceride. The combination is common formulation practice in microbial balance blends.

Monolaurin (Lauric Acid Derivative) + LipaseEnzymatic hydrolysis of the ester bond

Pancreatic lipase and intestinal esterases cleave monoacylglycerols to free fatty acid and glycerol. Added lipase in a digestive enzyme blend acts on the same bond, so it shifts the ratio of intact monoglyceride to free lauric acid reaching the lower gut. Whether that matters depends on which of the two forms a formula is aiming at.

Monolaurin is a solid at room temperature and disperses poorly in water. Lecithin phospholipids lower interfacial tension and hold it in a dispersed state, which is why lecithin appears in liquid and softgel presentations. This is formulation chemistry rather than a physiological interaction.

Monolaurin (Lauric Acid Derivative) + PhosphatidylcholineAmphiphilic carrier for a poorly dispersible lipid

Phosphatidylcholine forms mixed micelles with monoacylglycerols during normal fat digestion, the same physical process that carries dietary lipid across the enterocyte membrane. In a formula it serves as a dispersing vehicle. The chemistry is settled; the effect on how much intact monolaurin survives digestion has not been measured in people.

Tocopherols are the conventional chain-breaking antioxidant in oil-based and lipid-pellet products. They protect the carrier oil more than the saturated monoglyceride itself, since a saturated C12 chain has no double bonds to oxidise. The pairing is about shelf chemistry, not about a shared action in the body.

Monolaurin (Lauric Acid Derivative) + C8 MCT oilSolvent and carrier used in the same medium-chain lipid family

Caprylic acid triglyceride is liquid at room temperature and dissolves monolaurin readily, which makes it the usual carrier in liquid presentations. Both are medium-chain lipids that reach the portal circulation more directly than long-chain fats. Read the pairing as delivery chemistry plus a shared class, not as a combination with a measured joint outcome.

Monolaurin (Lauric Acid Derivative) + ProbioticsSurfactant lipids act on bacterial membranes generally

Monolaurin disrupts lipid membranes without selecting between organisms, and laboratory work on monoglycerides shows activity across gram-positive bacteria. Supplemented lactobacilli are gram-positive. Spacing the two doses is common formulation practice; the interaction is demonstrated in vitro and its size in a human gut is unmeasured.

Monolaurin (Lauric Acid Derivative) + Saccharomyces boulardiiYeast cell wall differs from a bacterial membrane

S. boulardii is a yeast with a chitin and glucan wall rather than a bacterial phospholipid bilayer of the kind monoglyceride surfactants act on most readily. That structural difference is the reason the yeast probiotic is the one usually paired with antimicrobial lipids. The reasoning is microbiological, and no combination trial in people is available.

Monolaurin (Lauric Acid Derivative) + Beta glucan yeastDifferent arm of normal immune signalling

Yeast beta-glucan is recognised by dectin-1 on innate immune cells, a receptor pathway with nothing to do with membrane-active lipids. Formulators combine them because the two routes are independent rather than overlapping. Each has its own literature; the pair does not.

Monolaurin (Lauric Acid Derivative) + Vitamin D3Cofactor role in normal immune cell function

Calcitriol acts through the vitamin D receptor on monocytes and lymphocytes and supports the normal expression of endogenous antimicrobial peptides. That is a transcriptional route and monolaurin is a physical membrane agent, so the two contribute to normal immune function by wholly separate means. The vitamin D receptor biology is settled; the pairing has not been studied as a pair.

Monolaurin (Lauric Acid Derivative) + ZincEstablished cofactor requirement for normal immune cell function

Zinc is structural in hundreds of enzymes and transcription factors, including those governing lymphocyte development. Its role in normal immune competence is textbook nutrition. Combining it with a membrane-active lipid pairs a nutrient requirement with a physical mechanism, which is why immune formulas carry both.

Monolaurin (Lauric Acid Derivative) + Colostrum bovineComplementary immunoglobulin and glycoprotein content

Bovine colostrum contributes IgG and glycoproteins that act in the gut lumen, an entirely different mode from a surfactant lipid. The two are combined in gut-directed formulas on that complementary logic. Human data on the combination is not available.

Monolaurin (Lauric Acid Derivative) + Aged garlic extractDifferent chemistry aimed at the same formulation slot

Aged garlic contributes S-allyl cysteine and related organosulfur compounds, which act through thiol chemistry rather than membrane disruption. Blends pair them for that non-overlap. The rationale is mechanistic and the pair has no clinical study behind it.

Monolaurin (Lauric Acid Derivative) + BerberineIndependent mechanism in the same gut-directed category

Berberine is a quaternary isoquinoline alkaloid with poor oral bioavailability, so much of a dose acts in the gut lumen. Monolaurin also acts substantially in the lumen but by physical membrane interaction. Two different routes in the same compartment is the formulation argument; no combination data exists.

Monolaurin (Lauric Acid Derivative) + PropolisPolyphenol and flavonoid contribution alongside a lipid

Propolis carries galangin, pinocembrin and caffeic acid esters, all polyphenols rather than lipids. Traditional immune blends combine the two categories. This one is thin: traditional use plus separate laboratory work on each, not a study of the pair.

Who should be cautious

Nothing specific on file for Monolaurin (Lauric Acid Derivative). Match the label to the daily amount above, and tell your doctor what you take.

Not medical advice. Show the label to your pharmacist.

What Monolaurin (Lauric Acid Derivative) actually does.

Established

Monolaurin is glycerol monolaurate, the monoester of the twelve-carbon saturated fatty acid lauric acid with glycerol. The molecule is amphiphilic: a polar glycerol head with two free hydroxyls and a single saturated tail, which is what lets it insert into lipid bilayers.

Established

Normal fat digestion produces monoacylglycerols from dietary triglyceride through pancreatic lipase acting at the sn-1 and sn-3 positions. Monolaurin taken orally therefore enters an existing metabolic route rather than a novel one, and intestinal esterases can hydrolyse it back to lauric acid and glycerol.

Established

Medium-chain fatty acids released in the gut are absorbed and carried largely by the portal vein bound to albumin, bypassing the chylomicron and lymphatic route that long-chain fats take. Chain length, not the supplement label, decides which route applies.

Established

Coconut and palm kernel oils are the practical lauric acid feedstocks because roughly half of their fatty acid content is C12, which is unusual among common food fats.

More than one route, 6 steps on record

Where Monolaurin (Lauric Acid Derivative) comes from.

Coconut oil is split into its fatty acids, the twelve-carbon one is separated out, and it is joined back onto glycerol either with heat and a catalyst or with an enzyme. A vacuum distillation step cleans up the leftovers, and the batch is tested for how much of the single-tailed molecule it actually contains.

The same molecule is reached more than one way. Which route a given product used is a manufacturing choice, and the finished compound is the same either way.

Starts as
Coconut or palm kernel oil

Both are unusually rich in the twelve-carbon fatty acid, roughly half their fatty acid content, which is why they are the commercial starting point.

Converted by
Hydrolysis and fractional distillation to lauric acid

The triglyceride is split by high-pressure steam hydrolysis into free fatty acids and glycerol, then fractionally distilled to separate the C12 cut from shorter and longer chains.

Converted by
Esterification with glycerol

Lauric acid is reacted with glycerol. The route may be chemical, using an alkaline catalyst at elevated temperature, or enzymatic, using an immobilised lipase at lower temperature. Chemical esterification runs faster and gives a broader mix of mono-, di- and triester; the enzymatic route runs milder and more selectively for the monoester and costs more per kilogram.

Purified by
Molecular distillation

Short-path distillation under high vacuum removes unreacted acid, glycerol and most of the diester, raising monoester content toward 90 percent or higher.

Standardised to
Monoester assay

Batches are assayed by gas chromatography for monoester content and free glycerol. The declared figure is monoester percentage.

Ends up as
Pellets, oil dispersion or lecithin blend

Molten material is prilled into pellets, dissolved into an MCT carrier, or co-processed with lecithin for dispersible powders.

Getting Monolaurin (Lauric Acid Derivative) from food.

The whole-food sources on file. A supplement closes the gap, it does not replace dinner.

Varied diet

A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.

The forms it comes in.

Monolaurin (glycerol monolaurate) pelletsSolid monoester, typically 90 percent or higher monoester with residual di- and triester and free glycerolFits Capsules and loose pellets where a dry, unflavoured dose is wantedTrade-off Pellets are waxy and can be unpleasant to take loose, and the residual diester fraction is rarely declared on a label
Monolaurin in MCT oilMonoester dissolved in a caprylic and capric triglyceride carrierFits Softgels and liquid dosing, and formulas that already run on a lipid baseTrade-off The carrier occupies most of the volume, so the deliverable amount per softgel is limited by capsule size
Monolaurin with sunflower lecithinMonoester co-processed with phospholipid to give a dispersible matrixFits Powder blends and beverages where the material has to wet out in waterTrade-off Lecithin adds its own phospholipid and choline load to the formula, which matters when other ingredients already contribute itActive and formulation aid
Lauric acidFree C12 saturated fatty acid, not esterified to glycerolFits Formulas declaring the fatty acid itself, and as the manufacturing input for the monoesterTrade-off It is a different molecule from the monoglyceride, with different solubility and different membrane behaviour, so the two labels are not interchangeable
What the strongest studies found

The essence, in one line each.

  1. A medium-chain triglyceride emulsion containing phytocannabinoids and monolaurin was reported to improve growth and survival in suckling piglets, and the design cannot separate the monolaurin contribution from the rest of the emulsion.Animal study. Kongkeaw et al., 2025 (Animals). PMID 41096476
  2. In a prospective observational cohort, higher measured serum monolaurin concentration was associated with lower odds of a subsequent viral respiratory illness outcome; this is an association in observed data and not evidence that supplementation caused the difference.Cohort study. Sola et al., 2025 (International Journal of Molecular Sciences). PMID 40141096

These are the studies our verdict leans on, chosen from the 2 we read for Monolaurin (Lauric Acid Derivative). The full linked list is below.

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.